GEN1046 Safety Trial in Patients With Malignant Solid Tumors

PHASE1,PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

429

Enrollment

INDUSTRY

Sponsor class

Conditions

BIOLOGICAL: Acasunlimab
BIOLOGICAL: Acasunlimab in combination with docetaxel (in a single expansion cohort)
BIOLOGICAL: Acasunlimab in combination with pembrolizumab (in a separate expansion cohort)
BIOLOGICAL: Acasunlimab in combination with pembrolizumab and standard chemotherapy (in separate expansion cohorts)

Genmab